REGISTERED COMPANY NUMBER: |
REGISTERED CHARITY NUMBER: |
Report of the Trustees and |
Unaudited Financial Statements |
for the Year Ended 31 December 2023 |
for |
SYMPOSIUM MAMMOGRAPHICUM |
REGISTERED COMPANY NUMBER: |
REGISTERED CHARITY NUMBER: |
Report of the Trustees and |
Unaudited Financial Statements |
for the Year Ended 31 December 2023 |
for |
SYMPOSIUM MAMMOGRAPHICUM |
SYMPOSIUM MAMMOGRAPHICUM |
Contents of the Financial Statements |
for the Year Ended 31 December 2023 |
Page |
Report of the Trustees | 1 | to | 9 |
Independent Examiner's Report | 10 | to | 11 |
Statement of Financial Activities | 12 |
Balance Sheet | 13 | to | 14 |
Notes to the Financial Statements | 15 | to | 19 |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
The Trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2023. The Trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). |
OBJECTIVES AND ACTIVITIES |
Objectives and aims |
The charity's objectives and aims are to promote research and to disseminate knowledge about improvements in methods and techniques for the prevention, diagnosis and treatment of breast disease - cancer and other disorders. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
OBJECTIVES AND ACTIVITIES |
Significant activities |
Conference |
The charity's 21st conference (symposium) took place at the Scottish Events Campus, Glasgow from 21st to 23rd June 2023. Much of the planning took place in 2022, with reference to the scientific programme and technical exhibition. |
The conference programme consisted of the usual keynote addresses and plenary sessions, along with parallel and proffered paper sessions and satellite symposia. There was a rich and diverse choice of educational workshops which were very well received and a wide range of poster topics. The conference was attended by over 650 delegates who welcomed the forum to meet face to face for the first time since 2018 (as the previous conference in 2021 took place on line). Most of the sessions were recorded so that delegates could access the presentations on line after the event. |
The Organising Committee for the 2023 event was chaired by Dr Sarah Tennant and vice chair, Dr Sarah Vinnicombe, both Trustees. The Committee is made up of Trustees as well as invited members from a range of disciplines to complement the core team and enhance the conference programme. |
Working with other organisations |
The charity, as part of its enthusiasm to widen the scope of the event, continues to collaborate with the Association of Breast Clinicians to help promote greater exchange of knowledge and debate within the conference. |
A reciprocal arrangement hosting a session at each other's events is now established with the Association of Breast Surgery (ABS). A dedicated session at Symposium Mammographicum about surgery was include in the Symposium Mammographicum conference in June 2023, Joint ABS session: Surgery update, chaired by Sarah Downey, Vice President, ABS and Nisha Sharma, Symposium Mammographicum. Plans for Symposium Mammographicum to have a badged session at the ABS conference in May 2024 were planned. |
The charity continued to embed its relationship with the Society of Radiologists in Training (SRT). Training workshops, organised by Ms Sue Garnett, Trustee, were embedded into the programme. The workshops were supported by fellow Trustee, Ms Zebby Rees, and Ms Samantha Smith, appointed as a Trustee in December 2023. Dr Nisha Sharma, Trustee, was a speaker at the conference. |
Symposium Mammographicum re-established its presence at the UKIO (UK Imaging and Oncology) Conference in 2022 after the hiatus caused by the Covid-19 pandemic. Due to the proximity of the UKIO conference taking place so close to Symposium Mammographicum own event, it was decided to defer the charity's presence and support the running of biopsy workshops in 2024. |
Work also continued during 2023 to progress opportunities to work with the Association of Breast Pathology, and the organisers of the UK Interdisciplinary Breast Cancer Symposium (UKIBCS). This latter organisation has appointed Dr Vinnicombe already on the UKIBCS committee in her own right. The UKIBCS event planned for January 2024 would include a dedicated session on breast radiology, and scheduled to take place in Birmingham. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
OBJECTIVES AND ACTIVITIES |
Volunteers |
The charity receives support from a number of experts who have joined the COC, who provide additional expertise to develop the scientific programme for the biennial conference. The Trustees are grateful for the time and dedication that the additional COC members contribute, considerably enriching the conference programmes. |
ACHIEVEMENT AND PERFORMANCE |
Charitable activities |
Symposium Mammographicum promotes an Award scheme of up to £2,500 each for radiologists, radiographers or other members of the diagnostic breast team residing and working in the United Kingdom. These can consist either of an Educational Award - to take up a secondment at a recognised centre in the UK or overseas to study a particular aspect of breast imaging practice, or a Research Award - to undertake a small research project related to breast imaging. The aim of the Awards is to support work which will contribute to improvement in the practice of breast imaging in the UK. |
The charity also provides bursaries for applicants from outside the United Kingdom, which aim either to facilitate study by an observational clinical attachment in a specialist training centre in the United Kingdom over a period of one or two weeks, or to facilitate attendance at the Symposium Mammographicum conference. The bursary scheme is also now open to certain groups of people within the UK to apply for funding to attend the Symposium or undertake a clinical observation placement. Eligible groups include public/patient representatives, professionals looking to return to work within breast services after a career break, and students interested in entering the breast specialism within the radiography or radiology disciplines. |
The Trustees continued to review ways of promoting the Award and Bursary schemes via web-based directories and on the websites of supportive organisations which hold similar objectives to Symposium Mammographicum. This has included support from the Higher Education Institutes to help attract radiography students. |
FINANCIAL REVIEW |
Principal funding sources |
The Charity's principal sources of funding are the registration fees, exhibitors' payments and sponsorship of the symposia, all within the biennial conference. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
FINANCIAL REVIEW |
Investment policy and objectives |
The Trustees regularly monitor the return on the savings accounts, noting the interest rates and potential access to the reserves, and take a balanced approach given the degree of risk in arranging conferences. Following the Trustees' considered review of investments from mid-2015 to late 2016 with guidance from investment advisors (Sanlam), it was decided to maintain the current investment profile, with the caveat that regular benchmarking studies to compare interest rates would be undertaken to maximise the return. Such a review was undertaken in 2017 from which Trustees supported the transfer of funds from the then current saving facilities to different banks which offered more attractive interest rates. This exercise was completed in autumn 2017. Performance would be subject to review to ensure the charity was able to secure a competitive return on investment, balanced against risk and accessibility to its reserves. This aspect is considered regularly by the Trustees at each Board meeting, as part of the incorporation of the longer-term financial view as a standing item. In September 2023, Trustees agreed to support the closure of one of its savings accounts and transfer the balance to its other savings account as it bore a much higher rate of interest. This transfer took place in December 2023. |
Reserves policy |
The Trustees are conscious of the need to optimise the level of reserves the charity has at its disposal. In considering the level, attention has focused on the charity's operational needs, noting the significant up-front costs (and resultant potential risk) in setting up a conference. Regard was also paid to the perception of risk and effects that external influences could have on income (for example, delegate numbers, exhibition size and income, venue costs, economic climate, reputation), mindful of the charity's objects and their continuing relevance. A summary review of the Reserves Policy was undertaken in 2017 and a detailed review was completed in 2021 to reflect the change in circumstances arising from the pandemic. |
Financial Management Review |
Trustees introduced a more robust set of measures to provide greater clarity on the charity's standing and financial robustness in 2021, in tandem with the reserves policy and strategy. The measures included the adoption of longer-range forecasting over a two year cycle at each meeting to help provide assurance and highlight any risks with the projected and committed expenditure countered by income levels, based on financial cycle of past conferences. In addition, to help minimise running costs to the charity, Trustees now alternate their quarterly meetings between meeting in person and using online video conferencing. Trustees are grateful to fellow Trustee, Ms Burch for providing her valued support by enhancing the way financial information is now being presented. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
FUTURE PLANS |
Strategic |
Arrangements for the Bournemouth International Centre in Bournemouth to host the 22nd Symposium Mammographicum conference from the 9th to 11th July 2025 are underway. An Organising Committee was established in December 2023, with Dr Sarah Vinnicombe as Chair and Dr Nisha Sharma as Vice-Chair. |
The Committee is made up of Trustees as well as invited experts from a range of disciplines to complement the core team and enhance the conference programme. The close collaboration with the Association of Breast Clinicians continues, with them organising their own sessions in parallel to the main SM programme, including availing of the occasion to hold their AGM. The programme 2025 will also build on the multi-disciplinary element and plans to incorporate a physics training event into the programme are being explored. |
Membership / Supporters scheme |
Trustees continued to review the current arrangements and considered a range of ways to encourage support to Symposium Mammographicum, which included options for setting up a supporters' network. The charity's website was updated with information about how people could support Symposium Mammographicum, establishing PayPal and Just Giving links to receive donations as well as describing ways to leave a legacy via a will. |
The Trustees are grateful for the continuing support from Members, (typically former Trustees) particularly with ongoing support with some of the collaborative work with other educational bodies such as the Society of Radiologists in Training. |
It was with great sadness that current and former Trustees noted the death of Mr Andrew Stebbings on the 9th June 2023 at the age of 72, after a long illness due to cancer. Andrew had a been a Trustee for 20 years from 1994 and was the son of Sir John Stebbings, who helped form the charity with Dr Audrey Tucker. |
Operational |
Trustees undertook a tendering exercise to review the services provided by the conference management company at end of conference organising cycle in September 2023 to ensure the charity was receiving best value for money. Following a competitive shortlisting process and interviews in November 2023, Profile Productions were reappointed to undertake the management and promotion of the 2025 event, scheduled to take place at the Bournemouth International Centre in Bournemouth. |
The charity appointed Sandison Lang & Co to provide an independent examination of their annual report and accounts, with effect from 1 January 2023. This proposal was supported at the Annual General Meeting on the 21 September 2022. |
STRUCTURE, GOVERNANCE AND MANAGEMENT |
Governing document |
The charity is a company limited by guarantee as defined by the Companies Act 2006 and is governed by its Memorandum and Articles of Association. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
STRUCTURE, GOVERNANCE AND MANAGEMENT |
Organisational structure |
The charity's Trustees met four times in 2023, to manage its affairs, ensuring that its work is in line with its mission and aims, providing a strategic overview of the running of the conference and associated activities, finance and budget monitoring, investments, succession planning, and receiving and reviewing of award and bursary applications. Running consecutively, the Conference Organising Committee (COC) met five times, chaired by Trustee Dr Sarah Tennant with fellow Trustee Dr Sarah Vinnicombe as its Vice-Chair. The expertise of the Trustees is augmented on the COC by the appointment of: |
- Ms Charlotte Hawke, Senior Radiographer & Clinical Trainer, Sherwood Forest Hospital Trust |
- Dr Lara Jehanli, Radiology Trainee, Countess of Chester Hospital and President of the Society of Radiologists in Training |
- Ms Lyndsay Kinnear, Training and Education Lead, Nightingale Centre, Manchester |
- Miss Michelle Mullan, Consultant Breast Surgeon, North Bristol NHS Trust |
- Dr Keerthini Muthuswamy, Radiology Registrar, National Medical Director's Clinical Fellow, Guy's and St Thomas NHS Foundation Trust, London |
- Dr Marianna Telesca, Consultant Breast Radiologist, Worcestershire Acute Hospitals NHS Trust. |
The COC for the 2023 conference continued until September 2023 and superseded by a new COC in December 2023 to support the 2025 conference. The Trustees are supported by: |
- Ms Lucy Cielecki, Consultant Radiographer in Breast Imaging, Shrewsbury and Telford Hospitals NHS Trust |
- Ms Noelle Clerkin, Deputy Breast Service Manager, Belfast Breast Unit |
- Dr Elisabetta Giannotti, Consultant Breast Radiologist, Cambridge University Hospitals |
- Dr Zoe Goldthorpe, Associate Specialist Breast Clinician, Director, Somerset Breast Screening, Vice President, Association of Breast Clinicians. |
- Helen Taylor, Service Lead Breast Imaging, Superintendent Radiographer, Gloucestershire Breast Imaging Department. |
In addition, the charity continued to work closely with the Association of Breast Clinicians, represented by Dr Cathy Coleman, who is also a Trustee of Symposium Mammographicum. |
The Symposium attracts members of the medical and allied health professions from around the UK and from around the world. Manufacturers of medical equipment are invited for the purpose of presenting their own expertise and information and learning from the like presentation of others. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
STRUCTURE, GOVERNANCE AND MANAGEMENT |
Trustees |
There were four resignations and four appointments, changing the constituency of the Board of Trustees in 2023. In September, Dr Barbara Dall, Ms Sue Garnett, Dr Anna Murphy and Ms Zebby Rees resigned after a collective 43 years' enthusiastic service to the charity. In December, Dr Nuala Healy, Dr Claire Mercer, Ms Samantha Smith and Dr Marianna Telesca were appointed. |
Dr Patsy Whelehan continued in her role of Chair of Trustees and Dr Michael Michell as the charity's President. The Trustee Board remains cognisant of the need to review succession planning, a topic discussed at board meetings on a regular basis. Discussions regarding the charity's constitution has been ongoing, with plans to establish a finite number of three-year terms of office for Trustees, creating the role of Co-Chair of Trustees to formalise the sharing of responsibilities was agreed in December 2023 with plans to put formal proposals for changing its Memorandum and Articles of Association in 2024. |
Risk management |
The Trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. During the year, Trustees have continued to review risks by updating and refining the Risk Register, which has led to: |
- assessing contract risk |
- further reviewing the Reserves Policy |
- assessing the Investment Policy |
- reviewing safeguards against fraudulent activity by those with access to the charity's bank accounts |
- continuing regular monitoring of income, expenditure, and effective management of the biennial symposia. |
The Risk Register is reviewed formally on an annual basis and financial risks are considered at each meeting. |
Fraud and Ethics Policy |
Following a review of the Charity Commission's best practice guidance about Fraud, Anti Bribery and Ethics, a Policy on these matters regarding fraud and ethics was developed and agreed in March 2017. |
It is noted that Trustees and the Company Secretary already receive training and guidance regarding fraud, bribery, conflicts of interest and safeguarding by virtue of their professional roles in the National Health Service. |
Complaints Policy |
Following a review of the Charity Commission's best practice guidance, a Complaints Policy was developed and agreed in March 2019. |
Document Retention Policy |
A policy to regularise documents managed and retained by the Secretary was established in June 2022, in terms of paper and electronic records, along with the appropriate measures for secure disposal of records falling outside the statutory / best practice retention periods. |
Legislation |
The Trustees were mindful of potential changes to the data protection regulations (GDPR) and considered the changes in charity legislation under the Charities Act 2022. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
REFERENCE AND ADMINISTRATIVE DETAILS |
Registered Company number |
Registered Charity number |
Registered office |
Trustees |
Dr N Healy (appointed 13.12.2023) |
Dr C Mercer (appointed 13.12.2023) |
Ms S Smith (appointed 13.12.2023) |
Dr M Telesca (appointed 13.12.2023) |
Company Secretary |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Report of the Trustees |
for the Year Ended 31 December 2023 |
REFERENCE AND ADMINISTRATIVE DETAILS |
Independent Examiner |
Mr Ryan Cottington ACA |
Sandison Lang Limited |
2 St Marys Road |
Tonbridge |
Kent |
TN9 2LB |
This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies. |
Approved by order of the board of Trustees on |
Independent Examiner's Report to the Trustees of |
Symposium Mammographicum |
Independent examiner's report to the trustees of Symposium Mammographicum ('the Company') |
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2023. |
Responsibilities and basis of report |
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'). |
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act. |
Independent Examiner's Report to the Trustees of |
Symposium Mammographicum |
Independent examiner's statement |
Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies. |
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe: |
1. | accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or |
2. | the accounts do not accord with those records; or |
3. | the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or |
4. | the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)). |
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. |
Mr Ryan Cottington ACA |
Sandison Lang Limited |
2 St Marys Road |
Tonbridge |
Kent |
TN9 2LB |
25 September 2024 |
SYMPOSIUM MAMMOGRAPHICUM |
Statement of Financial Activities |
for the Year Ended 31 December 2023 |
2023 | 2022 |
Unrestricted |
funds | Total funds |
Notes | £ | £ |
INCOME AND ENDOWMENTS FROM |
Donations and legacies |
Charitable activities |
( |
) |
Investment income | 2 |
Total | ( |
) |
EXPENDITURE ON |
Charitable activities |
NET INCOME/(EXPENDITURE) | ( |
) | ( |
) |
RECONCILIATION OF FUNDS |
Total funds brought forward |
TOTAL FUNDS CARRIED FORWARD | 120,634 |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Balance Sheet |
31 December 2023 |
2023 | 2022 |
Unrestricted |
funds | Total funds |
Notes | £ | £ |
CURRENT ASSETS |
Debtors | 5 |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 6 | ( |
) | ( |
) |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
NET ASSETS |
FUNDS | 7 |
Unrestricted funds | 120,634 |
TOTAL FUNDS | 120,634 |
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023. |
The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006. |
The trustees acknowledge their responsibilities for |
(a) | ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company. |
SYMPOSIUM MAMMOGRAPHICUM (REGISTERED NUMBER: 01886866) |
Balance Sheet - continued |
31 December 2023 |
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime. |
The financial statements were approved by the Board of Trustees and authorised for issue on |
SYMPOSIUM MAMMOGRAPHICUM |
Notes to the Financial Statements |
for the Year Ended 31 December 2023 |
1. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. |
Income |
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. |
Expenditure |
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. |
Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. |
Taxation |
The charity is exempt from corporation tax on its charitable activities. |
2. | INVESTMENT INCOME |
2023 | 2022 |
£ | £ |
Deposit account interest |
SYMPOSIUM MAMMOGRAPHICUM |
Notes to the Financial Statements - continued |
for the Year Ended 31 December 2023 |
3. | TRUSTEES' REMUNERATION AND BENEFITS |
There were no trustees' remuneration or other benefits for the year ended 31 December 2023 nor for the year ended 31 December 2022. |
Trustees' expenses |
Trustees expenses consist of the following: |
Room hire - £3,810 |
Trustee meetings - £2,093 |
Travel to Glasgow - £4,672 |
4. | COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES |
Unrestricted |
funds |
£ |
INCOME AND ENDOWMENTS FROM |
Charitable activities |
( |
) |
Investment income |
Total | ( |
) |
EXPENDITURE ON |
Charitable activities |
NET INCOME/(EXPENDITURE) | ( |
) |
RECONCILIATION OF FUNDS |
Total funds brought forward |
TOTAL FUNDS CARRIED FORWARD | 120,634 |
SYMPOSIUM MAMMOGRAPHICUM |
Notes to the Financial Statements - continued |
for the Year Ended 31 December 2023 |
5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2023 | 2022 |
£ | £ |
Trade debtors |
VAT |
Prepayments |
6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2023 | 2022 |
£ | £ |
Other creditors |
Accruals and deferred income |
7. | MOVEMENT IN FUNDS |
Net |
movement | At |
At 1/1/23 | in funds | 31/12/23 |
£ | £ | £ |
Unrestricted funds |
General fund | 120,634 | (258 | ) | 120,376 |
TOTAL FUNDS | (258 | ) | 120,376 |
Net movement in funds, included in the above are as follows: |
Incoming | Resources | Movement |
resources | expended | in funds |
£ | £ | £ |
Unrestricted funds |
General fund | 306,321 | (306,579 | ) | (258 | ) |
TOTAL FUNDS | ( |
) | (258 | ) |
SYMPOSIUM MAMMOGRAPHICUM |
Notes to the Financial Statements - continued |
for the Year Ended 31 December 2023 |
7. | MOVEMENT IN FUNDS - continued |
Comparatives for movement in funds |
Net |
movement | At |
At 1/1/22 | in funds | 31/12/22 |
£ | £ | £ |
Unrestricted funds |
General fund | 143,271 | (22,637 | ) | 120,634 |
TOTAL FUNDS | 143,271 | (22,637 | ) | 120,634 |
Comparative net movement in funds, included in the above are as follows: |
Incoming | Resources | Movement |
resources | expended | in funds |
£ | £ | £ |
Unrestricted funds |
General fund | (6,571 | ) | (16,066 | ) | (22,637 | ) |
TOTAL FUNDS | (6,571 | ) | (16,066 | ) | (22,637 | ) |
A current year 12 months and prior year 12 months combined position is as follows: |
Net |
movement | At |
At 1/1/22 | in funds | 31/12/23 |
£ | £ | £ |
Unrestricted funds |
General fund | 143,271 | (22,895 | ) | 120,376 |
TOTAL FUNDS | 143,271 | (22,895 | ) | 120,376 |
SYMPOSIUM MAMMOGRAPHICUM |
Notes to the Financial Statements - continued |
for the Year Ended 31 December 2023 |
7. | MOVEMENT IN FUNDS - continued |
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: |
Incoming | Resources | Movement |
resources | expended | in funds |
£ | £ | £ |
Unrestricted funds |
General fund | 299,750 | (322,645 | ) | (22,895 | ) |
TOTAL FUNDS | 299,750 | (322,645 | ) | (22,895 | ) |
8. | RELATED PARTY DISCLOSURES |